TB control in India in the COVID era
Tài liệu tham khảo
https://covid19.who.int/region/searo/country/in WHO Coronavirus Disease (COVID-19) Dashboard. Accessed on 3rd July 2020, 2000 hrs.
https://www.who.int/publications-detail/covid-19-operational-guidance-for-maintaining-essential-healthservices-during-an-outbreak; 25th Mar. 2020 (World Health Organization).
Elston, 2017, The health impact of the 2014–15 Ebola outbreak, Publ Health, 143, 60, 10.1016/j.puhe.2016.10.020
Parpia, 2016, Effects of response to 2014–2015 Ebola outbreak on deaths from malaria, HIV/AIDS, and tuberculosis, West Africa, Emerg Infect Dis, 22, 433, 10.3201/eid2203.150977
2020
Thankappan, 2020, Combating corona virus disease 2019 and comorbidities: the Kerala experience for the first 100 days, Int J Non-Commun Dis, 5, 36, 10.4103/jncd.jncd_26_20
Liu, 2020, Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity, medRxiv
2019
2020
Straetemans, 2011, Assessing tuberculosis case fatality ratio: a meta-analysis, PloS One, 6, 10.1371/journal.pone.0020755
Huddart, 2020, Tuberculosis case fatality in India: a systematic review and meta-analysis, BMJ Global Health, 5, 10.1136/bmjgh-2019-002080
European Center for Disease Prevention and Control (ECDC). https://github.com/owid/covid-19-data/tree/master/public/data.
Liu, 2020, The reproductive number of COVID-19 is higher compared to SARS coronavirus, J Trav Med, 27, 10.1093/jtm/taaa021
Wingfield, 2020, Tackling two pandemics: a plea on world tuberculosis day, Lancet Respir Med, 8, 536, 10.1016/S2213-2600(20)30151-X
Kim, 2020, Rates of Co-infection between SARS-CoV-2 and other respiratory pathogens, J Am Med Assoc, 323, 2085, 10.1001/jama.2020.6266
Tadolini, 2020, Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases, Eur Respir J, 2001398, 10.1183/13993003.01398-2020
Motta, 2020, Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts, Pulmonology, 26, 233, 10.1016/j.pulmoe.2020.05.002
Stochino, 2020, Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital, Eur Respir J, 2001708, 10.1183/13993003.01708-2020
Crisan-Dabija, 2020, Tuberculosis and COVID-19 in 2020: lessons from the past viral outbreaks and possible future outcomes, medRxiv, 4, 20082917
Min Ong, 2020, Eur Respir J
Ansumana, 2017, Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014–2015 Ebola virus disease outbreak in West Africa, Int J Infect Dis, 56, 101, 10.1016/j.ijid.2016.10.010
Saunders, 2020, COVID-19, tuberculosis, and poverty: preventing a perfect storm, Eur Respir J, 56, 10.1183/13993003.01348-2020
Khurana, 2020, The (in) significance of TB and COVID-19 co-infection, Eur Respir J, 10.1183/13993003.02105-2020
Visca, 2020, Tuberculosis in the time of COVID-19: quality of life and digital innovation, Eur Respir J, 10.1183/13993003.01998-2020
Wilkinson, 2020, Tuberculosis and type 2 Diabetes Mellitus: an inflammatory danger signal in the time of COVID-19, Clin Infect Dis, ciaa747, 10.1093/cid/ciaa747
Ndjeka, 2020, Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?, Eur Respir J, 10.1183/13993003.01369-2020
Jamal, 2020, COVID-19: ensuring continuity of TB services in the private sector, Int J Tubercul Lung Dis, 220
Kumar, 2020, COVID-19 and TB co-infection - ’Finishing touch” in perfect recipe to ’severity’ or ‘death’, J Infect, 10.1016/j.jinf.2020.06.062
Zumla, 2020, Editorial). COVID-19 and tuberculosis—threats and opportunities, Int J Tubercul Lung Dis, 10.5588/ijtld.20.0387
Togun, 2020, Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes, Ann Clin Microbiol Antimicrob, 19, 21, 10.1186/s12941-020-00363-1
Smith, 2020, 1
Glaziou, 2020, Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020, medRxiv
2020, The potential impact of the Covid-19 response on tuberculosis in high-burden countries: a modelling analysis. Developed by Stop TB Partnership in collaboration with Imperial College, Avenir Health
2020